John E. Bishop, SVP, Pharmaceutical Scie at Momenta Pharma, holds 336.85K shares in Ardelyx (Ticker: ARDX), holds 0.00 shares in Forma Therapeutics Holdings (Ticker: FMTX), holds 93.52K shares in Momenta Pharma (Ticker: MNTA). Most recently, John E. Bishop Sold ― shares of Ardelyx on May 22, 2026 for an estimated value of $14.44K.
What is the percentage of profitable transactions made by John E. Bishop?
The percentage of profitable transactions made by John E. Bishop is 100%.
What is the average return per transaction made by John E. Bishop?
The average return per transaction made by John E. Bishop is 11.00%.
What stocks does John E. Bishop hold?
John E. Bishop holds: MNTA, FMTX, LYRA, ARDX stocks.
What was John E. Bishop’s latest transaction?
John E. Bishop latest transaction was an Informative Sell of $14.44K.
What was John E. Bishop's most profitable transaction?
John E. Bishop’s most profitable transaction was an Informative Sell of ARDX stock on May 22, 2026. The return on the trade was 13.70%.
What is John E. Bishop's role in Momenta Pharma?
John E. Bishop's role in Momenta Pharma is SVP, Pharmaceutical Scie.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.